TB Alliance

Directions Website

TB Alliance is a non-profit product development partnership working to develop new, simpler, faster-acting TB drug treatments.

The TB Alliance is committed to supporting the development of Community Engagement (CE) strategies for clinical trials to serve as a bridge between trial researchers and local TB affected communities. Community Engagement strategies help to ensure that study participants, their families, community stakeholders, and others who may be affected by or at risk of TB infection, have an opportunity to partner with the scientific community in the implementation of research efforts. Community Engagement strategies can provide mechanisms for:

• educating communities about TB disease, treatment and the research process such as the different phases, the regulatory process, and in-built systems to ensure ethical conduct;
• obtaining community input into clinical trial implementation;
• understanding community perceptions and experiences, and identify community concerns so that they are addressed in the research process;
• liaising with community leaders to facilitate smooth implementation of clinical programs;
• sharing and discuss clinical trial and research results; and
• motivating communities to assist with policy and regimen change

10/14/2026

Say hello to Zakithi (Dr. Zakithi Mkhize)!

She’s a member of our inaugural TB Alliance Creator Collective: A team of engaged, impactful, and creative science and health communicators from all around the world who have signed on to help raise awareness about the world’s deadliest infectious disease.

Give her a follow, and get to know the rest of the Creator Collective at the link in bio.

10/08/2026

Meet the TB Alliance Creator Collective: A team of engaged, impactful, and creative science and health communicators from all around the world.

This year’s members include:

Arthur Menezes, PhD
Dr. Cambria Nwosu, DNP, RN, LNC
Danielle Spice
Fahira Novanra
Nicholas Jackson, PhD
Rashmi Rai
Zakithi Mkhize

Their goal is simple: Raise awareness about the deadliest infectious disease in the world, and the innovative science seeking to end it.

As members of the Creator Collective, they’ll attend the 2026 Union World Conference on Lung Health, as well as visit a community tuberculosis clinic in Rio de Janeiro, where they’ll learn directly from TB survivors, doctors, and the world's leading TB researchers, advocates, and community members.

Social media is the central source of information for millions around the world. The TB Alliance Creator Collective is built on a simple bet: Giving a small group of serious creators direct access to the work of ending tuberculosis will produce public health storytelling that makes an impact.

Give them a follow across their platforms to be part of the journey!

10/05/2026

This is what it looks like to take a medication that was made with people in mind.

Each year, more than one million children get sick with tuberculosis, and nearly 200,000 of them die — and part of the problem is inadequate treatment.

Years ago, there weren’t any medicines properly designed for kids. Children with tuberculosis were treated like adults – with large pills and bad-tasting medicines measured in too-large dosages. Treatment providers were left to split or crush pills to approximate proper doses. It made treatment a difficult guessing game, leading to poor results and difficult treatment.

So TB Alliance and partners stepped in and developed new, better treatments designed with kids in mind – medication that tastes good, dissolves in water, and is dosed appropriately. These child-friendly TB treatments have now been ordered by 137 countries around the world.

Learn more about how TB Alliance is helping revolutionize pediatric TB care at the link in bio.

09/28/2026

Our mission is simple ⬆️

09/22/2026

What is tuberculosis? And why is it still so deadly, despite available cures?

We need better (that means faster, simpler, cheaper, and more effective) treatments — and we need to make sure those treatments reach the people around the world who need them.

Learn more about TB — and the innovative science working to end it — at the link in bio.

09/10/2026

This photo shows the past and future of drug-resistant tuberculosis treatment.

Treatment for drug-resistant TB often used to take up to two years and as many as 14,000 pills, all just to have about a 30-50% chance at a cure.

Now, thanks to the work of TB Alliance and partners, there is a six month treatment that’s easier to take, has fewer adverse reactions, and is more affordable — with a cure rate of ~90%.

TB Alliance developed a new drug as part of a set three-drug, six-month, all-oral regimen. Since its release, this regimen has saved more than 20,000 lives and $160 million dollars globally for individuals and health systems.

Learn more about its impact at the link in bio.

Address

80 Pine Street
New York, NY
10005

Website

http://www.tballiance.org/

Alerts

Be the first to know and let us send you an email when TB Alliance posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.